Mark L. Pacala - 20 Nov 2025 Form 4 Insider Report for Oncology Institute, Inc. (TOI)

Role
Director
Signature
/s/ Mark Hueppelsheuser, Attorney-in-Fact for Mark L. Pacala
Issuer symbol
TOI
Transactions as of
20 Nov 2025
Net transactions value
$0
Form type
4
Filing time
24 Nov 2025, 17:21:04 UTC
Previous filing
20 Nov 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Pacala Mark L Director C/O THE ONCOLOGY INSTITUTE INC., 18000 STUDEBAKER RD, SUITE 800, CERRITOS /s/ Mark Hueppelsheuser, Attorney-in-Fact for Mark L. Pacala 24 Nov 2025 0001321250

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TOI Common Stock Award $0 +46,296 +26% $0.000000 221,267 20 Nov 2025 Direct F1
transaction TOI Common Stock Award $0 +35,494 +16% $0.000000 256,761 20 Nov 2025 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents restricted stock units that vest in full on Issuer's 2026 annual stockholder meeting date, subject to continued service with the Issuer through such vesting date.
F2 Represents restricted stock units that were fully vested upon grant.